Welcome to Business Insider‘s daily healthcare newsletter, your daily dose of pharma, biotech, and healthcare news. Subscribe here to get this newsletter in your inbox every weekday.
Hello,
Today in healthcare news: A doctor shares her experience taking part in a COVID-19 trial, an inside look at Oscar Health’s financials, and the role poor leadership plays in America’s coronavirus death toll.
I’m a doctor who volunteered to get one of the first coronavirus shots. Here’s why I got involved, and what the side effects have been like.
- Lisa Fitzpatrick, MD, MPH, is an infectious diseases doctor and medical epidemiologist living in the Congress Heights area of Washington, DC.
- She’s participating in the Phase 3 Moderna mRNA-1273 vaccine trial, which she signed up for to demonstrate her confidence in vaccine science during a time when “fear and distrust are flourishing.”
- It’s been an easy process so far, though she did experience mild side effects like soreness in her arm and fatigue.
Read the full personal essay by Dr. Lisa Fitzpatrick here>>
Here's a comprehensive look at the growth of Oscar Health since the hot health-insurance startup began signing up customers
- Founded in 2012, Oscar got its start on the individual exchanges implemented by the Affordable Care Act.
- It's grown to 420,000 members as of the start of 2020.
- Here's a look at Oscar's enrollment and financial performance from 2014 to 2020.
A new study finds poor leadership is the reason for America's unrivaled coronavirus death toll
- In the spring, many countries had high death rates, as the coronavirus circulated around the world unchecked.
- But in the months since then, most countries took simple steps to prevent disease transmission, and death rates fell dramatically.
- Except the US: the country has been a consistent outlier in coronavirus deaths.
- A new study shows just how bad the US lagged behind other rich countries over the summer, in disease control and prevention.
Read the full story from Hilary Brueck here>>
More stories we're reading:
- Moderna's CEO is aiming for an emergency authorization of its vaccine by December should it work (The Wall Street Journal)
- AstraZeneca's COVID-19 vaccine trial in the US could resume as soon as this week (Reuters)
- The DOJ just slammed Google with a landmark antitrust case, kicking off the largest legal challenge in the tech giant's history (Business Insider)
- 10 residents at a Kansas nursing home died after all 62 living there tested positive for COVID-19 (Insider)
Tell your friends and colleagues to subscribe here for daily updates from the healthcare team!
- Lydia
Read the original article on Business Insider